AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33653365 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 24
Study 32048478 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial awareness training (SA training)
Number of subjects: 104
Study 32048478 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SA training)
Number of subjects: 104
Study 34203487 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronan (HA) 120 mg daily for 12 weeks
Number of subjects: 40
Study 34203487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32362436 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive group ($10/day maximum for undetectable viral loads)
Number of subjects: 102
Study 32362436 — intervention group
Group type: COMPARATOR
Intervention: Usual Care group (no incentives)
Number of subjects: 102
Study 32029044 — intervention group
Group type: EXPERIMENTAL
Intervention: PiCCO monitoring for hemodynamics
Number of subjects: 60
Study 32029044 — intervention group
Group type: COMPARATOR
Intervention: Traditional ECG monitoring and lung sound, urine volume
Number of subjects: 60
Study 35215405 — intervention group
Group type: EXPERIMENTAL
Intervention: NMN (250 mg) administered once a day for 12 weeks
Number of subjects: 108
Study 35215405 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered once a day for 12 weeks
Number of subjects: 108
Study 34880007 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-week rehabilitation programme using the activity pacing framework
Number of subjects: 107
Study 34470137 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (200 mg daily)
Number of subjects: 58
Study 34470137 — intervention group
Group type: COMPARATOR
Intervention: 17-alpha-hydroxyprogesterone caproate (17OHP-C) (250 mg intramuscular weekly)
Number of subjects: 58
Study 33148218 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week staff-led and expert-supported intervention
Number of subjects: 116
Study 35201805 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 94
Study 35201805 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized CBT
Number of subjects: 94
Study 35201805 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 94
Study 33478533 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor residual spraying (IRS) with pirimiphos-methyl (PM)
Number of subjects: 10
Study 32058364 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-ingredient beverage (MTN)
Number of subjects: 10
Study 32058364 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate alone (CHO)
Number of subjects: 10
Study 33741236 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive voice therapy (1 hour, 4 days per week for 2 weeks)
Number of subjects: 20
Study 33741236 — intervention group
Group type: COMPARATOR
Intervention: Weekly voice therapy (1 hour per week for 8 weeks)
Number of subjects: 20
Study 33741236 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive voice therapy
Number of subjects: 20
Study 33741236 — intervention group
Group type: COMPARATOR
Intervention: Weekly voice therapy
Number of subjects: 20
Study 33674897 — intervention group
Group type: EXPERIMENTAL
Intervention: Saponin extract from Sesbania grandiflora pods meal (SES) at 0.6% of total substrate on a dry matter basis
Number of subjects: 0
Study 33674897 — intervention group
Group type: EXPERIMENTAL
Intervention: Saponin extract from Sesbania grandiflora pods meal (SES) at varying levels (0, 0.2, 0.4, and 0.6%)
Number of subjects: 0
Study 33674897 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude protein levels at 14% and 16%
Number of subjects: 0
Study 36089964 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed home physical education teaching model based on big data technology and artificial intelligence algorithm
Number of subjects: 0
Study 36089964 — intervention group
Group type: COMPARATOR
Intervention: Conventional online physical education teaching methods
Number of subjects: 0
Study 33246500 — intervention group
Group type: EXPERIMENTAL
Intervention: Barberry powder (BP; containing 10 g milled dried barberry and 1 g of milled sucrose)
Number of subjects: 74
Study 33246500 — intervention group
Group type: COMPARATOR
Intervention: Placebo powder (PP; containing 9 g maltodextrin, 1 g citric acid, 1 g milled sucrose and edible red color)
Number of subjects: 74
Study 34044603 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with multidisciplinary care
Number of subjects: 20
Study 32016386 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg intravenous zoledronate (ZZ, n = 16)
Number of subjects: 33
Study 32016386 — intervention group
Group type: COMPARATOR
Intervention: 5 mg intravenous zoledronate at 5.5 years (PZ, n = 17)
Number of subjects: 33
Study 34742297 — intervention group
Group type: EXPERIMENTAL
Intervention: Active non-invasive low-frequency nerve stimulation (LFS) for 3 months (minimum 10 min/day)
Number of subjects: 76
Study 34742297 — intervention group
Group type: COMPARATOR
Intervention: Sham non-invasive low-frequency nerve stimulation (LFS) for 3 months (minimum 10 min/day)
Number of subjects: 76
Study 34742297 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanistic study assessing somatosensory changes in response to LFS
Number of subjects: 76
Study 34215760 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model
Number of subjects: 190
Study 34215760 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) model
Number of subjects: 190
Study 34215760 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR) model
Number of subjects: 190
Study 34215760 — intervention group
Group type: COMPARATOR
Intervention: Radiologist diagnosis
Number of subjects: 190
Study 35372875 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil and/or aspirin
Number of subjects: 536
Study 35372875 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 536
Study 35372875 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with AVF failure
Number of subjects: 536
Study 35711093 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3547
Study 35711093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3547
Study 33408073 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating 27‐OHC at or above the fourth quartile (?201 ng/mL)
Number of subjects: 1246
Study 33408073 — intervention group
Group type: COMPARATOR
Intervention: Circulating 27‐OHC below the first quartile (<138 ng/mL)
Number of subjects: 1246
Study 33040113 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemoglobin
Number of subjects: 299
Study 33040113 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemoglobin and haematocrit; mean corpuscular volume; red cell distribution width
Number of subjects: 299
Study 33040113 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemoglobin and red blood cell count; haematocrit and red blood cell count; mean corpuscular haemoglobin and mean corpuscular haemoglobin concentration
Number of subjects: 299
Study 33040113 — intervention group
Group type: EXPERIMENTAL
Intervention: Red blood cell count and mean corpuscular volume; red blood cell count and red cell distribution width; red blood cell count and mean corpuscular haemoglobin
Number of subjects: 299
Study 33040113 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferritin level
Number of subjects: 299
Study 34550860 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity exercise, 60 minutes/day, 6 days/week for 12 months
Number of subjects: 202
Study 34550860 — intervention group
Group type: COMPARATOR
Intervention: Usual lifestyle (Control)
Number of subjects: 202
Study 34550860 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity exercise
Number of subjects: 202
Study 34089503 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA-guided adjuvant chemotherapy (AC)
Number of subjects: 0
Study 34089503 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference-sensitive ctDNA strategy
Number of subjects: 0
Study 34089503 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 35737565 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP14
Number of subjects: 600
Study 35737565 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP21
Number of subjects: 600
Study 32071191 — intervention group
Group type: EXPERIMENTAL
Intervention: MRC-funded clinical trials registered in a public trials registry
Number of subjects: 175
Study 32071191 — intervention group
Group type: EXPERIMENTAL
Intervention: MRC-funded clinical trials
Number of subjects: 175
Study 36066323 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ruxolitinib cream
Number of subjects: 1249
Study 36066323 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% ruxolitinib cream
Number of subjects: 1249
Study 36066323 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 1249
Study 33565041 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (gamma knife)
Number of subjects: 0
Study 33565041 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-guided high intensity focused ultrasound
Number of subjects: 0
Study 33565041 — intervention group
Group type: COMPARATOR
Intervention: Intensive residential treatment for OCD
Number of subjects: 0
Study 33565041 — intervention group
Group type: COMPARATOR
Intervention: Lesion surgery
Number of subjects: 0
Study 33565041 — intervention group
Group type: COMPARATOR
Intervention: Deep brain stimulation (DBS)
Number of subjects: 0
Study 33563173 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (300 mg/day)
Number of subjects: 64
Study 33563173 — intervention group
Group type: COMPARATOR
Intervention: Gabapentin (800 mg/day)
Number of subjects: 64
Study 33020394 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT), 15 min application, 1 min 30 s each muscular point, five muscular points in each lower limb
Number of subjects: 13
Study 33020394 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SHAM), 15 min application
Number of subjects: 13
Study 33020394 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 13
Study 33020394 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SHAM)
Number of subjects: 13
Study 35984721 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfragmented adipose tissue (MF-AT)
Number of subjects: 118
Study 35984721 — intervention group
Group type: COMPARATOR
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 118
Study 34468882 — intervention group
Group type: EXPERIMENTAL
Intervention: Best-Worst Scaling (BWS) using ASCOT-Carer
Number of subjects: 1005
Study 34468882 — intervention group
Group type: EXPERIMENTAL
Intervention: ASCOT-Carer profiles
Number of subjects: 1005
Study 34468882 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalised MNL model specifications
Number of subjects: 1005
Study 34468882 — intervention group
Group type: EXPERIMENTAL
Intervention: Scale multinomial logit (S-MNL) model
Number of subjects: 1005
Study 32152080 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 0
Study 32152080 — intervention group
Group type: COMPARATOR
Intervention: Morinidazole (MOR)
Number of subjects: 0
Study 35405631 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser auriculotherapy (10 sessions, twice a week)
Number of subjects: 47
Study 35405631 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 47
Study 34555200 — intervention group
Group type: EXPERIMENTAL
Intervention: 11 for Health in Denmark programme (IG)
Number of subjects: 1122
Study 34555200 — intervention group
Group type: EXPERIMENTAL
Intervention: 11 for Health in Denmark programme (IGPI subgroup)
Number of subjects: 1122
Study 34555200 — intervention group
Group type: EXPERIMENTAL
Intervention: 11 for Health in Denmark programme (IGPA subgroup)
Number of subjects: 1122
Study 36454969 — intervention group
Group type: EXPERIMENTAL
Intervention: 40Hz GENUS stimulation
Number of subjects: 15
Study 36454969 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 15
Study 34825617 — intervention group
Group type: EXPERIMENTAL
Intervention: Titrated group (received propofol at a rate of 1 mg/kg/min until the Observer's Assessment of Alertness/Sedation scale score reached 1 point)
Number of subjects: 160
Study 34825617 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (received 2 mg/kg propofol at a rate of 250 mg/min)
Number of subjects: 160
Study 35562711 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (5 mg/day initially, increased to 20 mg/day over 4 weeks)
Number of subjects: 10
Study 35562711 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 10
Study 35562711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 35570714 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure imagery
Number of subjects: 265
Study 35570714 — intervention group
Group type: COMPARATOR
Intervention: Anxious imagery
Number of subjects: 265
Study 35570714 — intervention group
Group type: COMPARATOR
Intervention: Avoidant imagery
Number of subjects: 265
Study 35570714 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperactivating strategies
Number of subjects: 265
Study 35570714 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppression strategies
Number of subjects: 265
Study 33220217 — intervention group
Group type: EXPERIMENTAL
Intervention: WHISPER intervention (mobile phone intervention focusing on contraception)
Number of subjects: 882
Study 33220217 — intervention group
Group type: COMPARATOR
Intervention: SHOUT control (nutrition-focused messages)
Number of subjects: 882
Study 36153153 — intervention group
Group type: EXPERIMENTAL
Intervention: AVP booster dose in Group A (on schedule)
Number of subjects: 596
Study 36153153 — intervention group
Group type: EXPERIMENTAL
Intervention: AVP booster dose in Group B (not on schedule for ≥2 years)
Number of subjects: 596
Study 36153153 — intervention group
Group type: EXPERIMENTAL
Intervention: AVP booster doses
Number of subjects: 596
Study 36153153 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxin Neutralisation Assay (TNA)
Number of subjects: 596
Study 34045160 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 pandemic impact on clinical, educational, and personal experiences
Number of subjects: 0
Study 33339971 — intervention group
Group type: EXPERIMENTAL
Intervention: Hall technique (HT)
Number of subjects: 0
Study 33339971 — intervention group
Group type: COMPARATOR
Intervention: Conventional restoration (CR)
Number of subjects: 0
Study 35189449 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth tissue-borne (TTB) rapid maxillary expansion appliance
Number of subjects: 46
Study 35189449 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-borne (TB) rapid maxillary expansion appliance
Number of subjects: 46
Study 35189449 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-borne (BB) rapid maxillary expansion appliance
Number of subjects: 46
Study 35189449 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study 32449130 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg/day resveratrol
Number of subjects: 66
Study 32449130 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 66
Study 33184629 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous d6-α-tocopherol with 600-kcal defined liquid meal (40% fat)
Number of subjects: 17
Study 33184629 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous d6-α-tocopherol with 600-kcal defined liquid meal (0% fat)
Number of subjects: 17
Study 33184629 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous d6-α-tocopherol with 0% fat DLM followed by a 12-h fast (0% fat-fast)
Number of subjects: 17
Study 33184629 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral d3-α-tocopherol with 600-kcal defined liquid meal (40% fat)
Number of subjects: 17
Study 33184629 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral d3-α-tocopherol with 600-kcal defined liquid meal (0% fat)
Number of subjects: 17
Study 33184629 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral d3-α-tocopherol with 0% fat DLM followed by a 12-h fast (0% fat-fast)
Number of subjects: 17
Study 33396626 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined low amylose wheat (LAW‐R) bread
Number of subjects: 6
Study 33396626 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined high amylose wheat (HAW‐R) bread
Number of subjects: 6
Study 33396626 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined high amylose wheat (HAW‐R) bread (measured in ileorectostomised rats)
Number of subjects: 6
Study 33396626 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional wheat breads
Number of subjects: 6
Study 33502416 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantago major supplementation (n = 35)
Number of subjects: 72
Study 35171260 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted radical cystectomy (RARC)
Number of subjects: 302
Study 35171260 — intervention group
Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 302
Study 34310672 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized self-organizing map algorithm
Number of subjects: 0
Study 32726552 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% lactic acid applied to one cheek
Number of subjects: 0
Study 32726552 — intervention group
Group type: COMPARATOR
Intervention: Water applied to the contralateral cheek as control
Number of subjects: 0
Study 34788812 — intervention group
Group type: EXPERIMENTAL
Intervention: Vedolizumab
Number of subjects: 0
Study 32325176 — intervention group
Group type: EXPERIMENTAL
Intervention: Type O veneer
Number of subjects: 40
Study 32325176 — intervention group
Group type: EXPERIMENTAL
Intervention: Type OF veneer
Number of subjects: 40
Study 32325176 — intervention group
Group type: EXPERIMENTAL
Intervention: Type POF veneer
Number of subjects: 40
Study 32325176 — intervention group
Group type: EXPERIMENTAL
Intervention: Type POFP veneer
Number of subjects: 40
Study 32325176 — intervention group
Group type: COMPARATOR
Intervention: Full crown
Number of subjects: 40
Study 35285487 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant osimertinib for 3 years
Number of subjects: 0
Study 35285487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35285487 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant osimertinib
Number of subjects: 0
Study 35285487 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant osimertinib with 50% discount
Number of subjects: 0
Study 33221229 — intervention group
Group type: EXPERIMENTAL
Intervention: FBBG
Number of subjects: 25
Study 33221229 — intervention group
Group type: COMPARATOR
Intervention: HED
Number of subjects: 25
Study 32841271 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal Weight Obesity (NWO)
Number of subjects: 1147
Study 32841271 — intervention group
Group type: COMPARATOR
Intervention: Overtly Obese (OB)
Number of subjects: 1147
Study 32841271 — intervention group
Group type: COMPARATOR
Intervention: Non-Obese (NO)
Number of subjects: 1147
Study 34387797 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual care intervention
Number of subjects: 71
Study 34387797 — intervention group
Group type: COMPARATOR
Intervention: Control group (no spiritual care)
Number of subjects: 71
Study 34520092 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy - Long (CBT-L)
Number of subjects: 100
Study 34520092 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy - Brief (CBT-B)
Number of subjects: 100
Study 34520092 — intervention group
Group type: COMPARATOR
Intervention: Wait-List (WL)
Number of subjects: 100
Study 32652064 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery protocol
Number of subjects: 168
Study 32652064 — intervention group
Group type: COMPARATOR
Intervention: Standard perioperative care
Number of subjects: 168
Study 35193718 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazil and cashew nuts group (BN-Group): energy-restricted diet containing daily 45 g of nuts (15 g of Brazil nuts + 30 g of cashew nuts)
Number of subjects: 40
Study 35193718 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazil and cashew nuts group (BN-Group)
Number of subjects: 40
Study 35193718 — intervention group
Group type: COMPARATOR
Intervention: Control group: energy-restricted diet without nuts
Number of subjects: 40
Study 34775184 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) - any use
Number of subjects: 77
Study 34775184 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum and nicotine patch used together
Number of subjects: 77
Study 34775184 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch alone
Number of subjects: 77
Study 34775184 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum alone
Number of subjects: 77
Study 33992980 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 149
Study 33992980 — intervention group
Group type: COMPARATOR
Intervention: Conventional model
Number of subjects: 149
Study 32634052 — intervention group
Group type: EXPERIMENTAL
Intervention: Group motivational interviewing
Number of subjects: 656
Study 32634052 — intervention group
Group type: COMPARATOR
Intervention: Very brief advice
Number of subjects: 656
Study 33470067 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic lymphadenectomy alone
Number of subjects: 64
Study 33470067 — intervention group
Group type: COMPARATOR
Intervention: Pelvic and para-aortic lymphadenectomy
Number of subjects: 64
Study 33470067 — intervention group
Group type: EXPERIMENTAL
Intervention: Omission of lymphadenectomy based on LNM scoring system
Number of subjects: 64
Study 32346896 — intervention group
Group type: EXPERIMENTAL
Intervention: VR cognitive stimulation activity
Number of subjects: 236
Study 32346896 — intervention group
Group type: COMPARATOR
Intervention: paper-and-pencil activity
Number of subjects: 236
Study 34664616 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinovac‐CoronaVac vaccine (2 doses, 28-day interval)
Number of subjects: 53
Study 32044750 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge Translation (KT) intervention including weekly email alerts and social media engagement for 12 weeks
Number of subjects: 510
Study 32044750 — intervention group
Group type: COMPARATOR
Intervention: Self-serve control group with access to the Portal without targeted KT strategies
Number of subjects: 510